Javascript must be enabled to continue!
ASSOCIATION OF HEALTHY LIFESTYLE INDEX AND ANTIHYPERTENSIVE MEDICATION USE WITH BLOOD PRESSURE CONTROL AMONG EMPLOYEES WITH HYPERTENSION IN CHINA
View through CrossRef
Objective:
We examined the association of antihypertensive medication use and HLI with BP control among employees with hypertension in China based on a workplace-based multicomponent intervention program.
Design and method:
A cluster randomized clinical trial of a workplace-based multicomponent intervention program was conducted in 60 workplaces across 20 urban areas in China. Workplaces were randomly divided into intervention (n = 40) and control (n = 20) groups. Basic information on employees at each workplace was collected by trained professionals, including sociodemographic characteristics, medical history, family history, lifestyle behaviors, medication status and physical measurements. After baseline, the intervention group received a 2-year intervention to achieve BP control, which included:(1) a workplace wellness program for all employees; (2) a guidelines-oriented hypertension management protocol. HLI including nonsmoking, nondrinking, adequate physical activity, weight within reference range and balanced diet, were coded on a 5-point scale (range, 0-5, with higher score indicating a healthier lifestyle). Antihypertensive medication use was defined as taking drug within the last 2 weeks. Changes in HLI, antihypertensive medication use and BP control from baseline to 24 months were measured after the intervention.
Results:
After 24 months of the intervention, there was a significant improvement in lifestyle [smoking (0.65, 95% CI, 0.43∼0.99; P=0.045), drinking (OR=0.52, 95% CI, 0.40∼0.68; P<0.001), regular exercise (OR=3.10, 95% CI, 2.53∼3.78; P<0.001), excessive intake of fatty food (OR=0.17, 95% CI, 0.06∼0.52; P=0.002), restrictive use of salt (OR=0.26, 95% CI, 0.12∼0.56; P=0.001)]. Compare to employees with a deteriorating lifestyle after the intervention, those with an improved lifestyle had a higher BP control. In the intervention group, compared with employees not using antihypertensive medication, those who consistent used (OR, 2.34; 95% CI, 1.16∼4.72; P=0.017) or changed from not using to using antihypertensive medication (OR, 2.24; 95% CI, 1.08∼4.62; P=0.030) had higher BP control. Those who used antihypertensive medication and had a high HLI had the highest BP control (OR, 1.88; 95% CI, 1.32∼2.67, P<0.001).
Conclusions:
These findings suggest that adherence to antihypertensive medication treatment and healthy lifestyle were associated with a significant improvement in BP control among employees with hypertension.
Ovid Technologies (Wolters Kluwer Health)
Title: ASSOCIATION OF HEALTHY LIFESTYLE INDEX AND ANTIHYPERTENSIVE MEDICATION USE WITH BLOOD PRESSURE CONTROL AMONG EMPLOYEES WITH HYPERTENSION IN CHINA
Description:
Objective:
We examined the association of antihypertensive medication use and HLI with BP control among employees with hypertension in China based on a workplace-based multicomponent intervention program.
Design and method:
A cluster randomized clinical trial of a workplace-based multicomponent intervention program was conducted in 60 workplaces across 20 urban areas in China.
Workplaces were randomly divided into intervention (n = 40) and control (n = 20) groups.
Basic information on employees at each workplace was collected by trained professionals, including sociodemographic characteristics, medical history, family history, lifestyle behaviors, medication status and physical measurements.
After baseline, the intervention group received a 2-year intervention to achieve BP control, which included:(1) a workplace wellness program for all employees; (2) a guidelines-oriented hypertension management protocol.
HLI including nonsmoking, nondrinking, adequate physical activity, weight within reference range and balanced diet, were coded on a 5-point scale (range, 0-5, with higher score indicating a healthier lifestyle).
Antihypertensive medication use was defined as taking drug within the last 2 weeks.
Changes in HLI, antihypertensive medication use and BP control from baseline to 24 months were measured after the intervention.
Results:
After 24 months of the intervention, there was a significant improvement in lifestyle [smoking (0.
65, 95% CI, 0.
43∼0.
99; P=0.
045), drinking (OR=0.
52, 95% CI, 0.
40∼0.
68; P<0.
001), regular exercise (OR=3.
10, 95% CI, 2.
53∼3.
78; P<0.
001), excessive intake of fatty food (OR=0.
17, 95% CI, 0.
06∼0.
52; P=0.
002), restrictive use of salt (OR=0.
26, 95% CI, 0.
12∼0.
56; P=0.
001)].
Compare to employees with a deteriorating lifestyle after the intervention, those with an improved lifestyle had a higher BP control.
In the intervention group, compared with employees not using antihypertensive medication, those who consistent used (OR, 2.
34; 95% CI, 1.
16∼4.
72; P=0.
017) or changed from not using to using antihypertensive medication (OR, 2.
24; 95% CI, 1.
08∼4.
62; P=0.
030) had higher BP control.
Those who used antihypertensive medication and had a high HLI had the highest BP control (OR, 1.
88; 95% CI, 1.
32∼2.
67, P<0.
001).
Conclusions:
These findings suggest that adherence to antihypertensive medication treatment and healthy lifestyle were associated with a significant improvement in BP control among employees with hypertension.
Related Results
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
HYPERURICEMIA AND ITS ASSOCIATION WITH HYPERTENSION: RISK FACTORS AND MANAGEMENT
HYPERURICEMIA AND ITS ASSOCIATION WITH HYPERTENSION: RISK FACTORS AND MANAGEMENT
Hyperuricemia is a medical condition that arises due to the increased concentration of uric acid in the body. Worldwide, a surge in the number of hyperuricemia cases has been seen ...
STRATEGIES FOR THE PREVENTION AND CONTROL OF HYPERTENSION IN RURAL COMMUNITIES
STRATEGIES FOR THE PREVENTION AND CONTROL OF HYPERTENSION IN RURAL COMMUNITIES
Hypertension is a prevalent chronic condition that can lead to serious complications such as cardiovascular disease, stroke and kidney failure. The prevalence of hypertension is es...
EFFECT OF DIFFERENT ANTIHYPERTENSIVE STRATEGIES ON THE MICROALBUMINURIA EXCRETION
EFFECT OF DIFFERENT ANTIHYPERTENSIVE STRATEGIES ON THE MICROALBUMINURIA EXCRETION
Objectives
Giving different therapy to hypertensive patients with microalbuminuria in order to find the appropriate individual therapy for this kind of high-risk ...
GW24-e2417 Insulin-like growth factor-I and brachial-ankle pulse wave velocity in patients with essential hypertension
GW24-e2417 Insulin-like growth factor-I and brachial-ankle pulse wave velocity in patients with essential hypertension
Objectives
To investigate the relationship between serum insulin-like growth factor-1 (IGF-1) and brachial-ankle pulse wave velocity (baPWV) in patients with esse...
Factors influencing medication adherence among hypertensive patients in primary care settings in Central Vietnam: A cross-sectional study
Factors influencing medication adherence among hypertensive patients in primary care settings in Central Vietnam: A cross-sectional study
Background
Medication adherence plays a crucial role in effectively managing hypertension, a significant public health concern, especially in regions like Central Vietnam. This stu...
Abstract 2233: Biobehavioral Factors and Heart Failure Medication Adherence
Abstract 2233: Biobehavioral Factors and Heart Failure Medication Adherence
Background:
Medication adherence in heart failure (HF) patients reduces hospitalizations and improves outcomes, yet it is variable. This study evaluated adherence rates...


